Stage II III IV |
85.7 ± 7.6 87 ± 7 53.3 ± 23.3 |
0.46 |
80 ± 9 73.9 ± 9.2 50 ± 11.2 |
0.108 |
Histopathology Mixed cellularity Nodular Scleroses Lymphocytic rich Lymphocytic Depletion |
76.7 ± 7.9 85.7 ± 9.4 100 100 |
0.568 |
65.1 ± 8.5 78.6 ± 11 100 66.7 ± 27.2 |
0.5 |
Extra nodal Involvement Absent Present |
91.2 ± 4.9 65.6 ± 12.2 |
0.036 |
78.8 ± 7.2 60 ± 11 |
0.11 |
Systemic Symptoms Absent (A) Present (B) |
92.9 ± 6.9 77.9 ± 7.2 |
0.28 |
84.4 ± 10.2 67.5 ± 7.4 |
0.2 |
Bulky Disease Absent Present |
93.5 ± 4.4 61.6 ± 13.6 |
0.015 |
80 ± 7.3 60.9 ± 10.2 |
0.09 |
Number of regions <4 ≥4 |
83.3 ± 10.8 81.4 ± 6.6 |
0.963 |
83.3 ± 710.8 68.5 ± 7.3 |
0.3 |
Early response No Yes |
80.4 ± 7.4 81.3 ± 9.8 |
0.8 |
67.7 ± 7.7 81.3 ± 9.8 |
0.36 |
RT No Yes |
30 ± 14.5 93.4 ± 4.7 |
<0.0001 |
30 ± 14.5 80.8 ± 6.1 |
<0.0001 |